Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries

Volumetric neuroimaging and traumatic brain injuries

Of the 1.5 million traumatic brain injuries (TBI) every year, 80% of them are considered mild. A “mild TBI”, often referred to as a concussion, is defined as loss of consciousness and/or confusion and disorientation, which is shorter than 30 minutes and an initial Glasgow Coma Scale (GCS) of 13-15.

A patient a with mild TBI does not initially present with any visible pathology, such as fractures, contusions, and hemorrhages. Long-term, however, the patient may possess disabling cognitive, psychological, and/or behavioral impairments and employment disabilities. In fact, recent studies have demonstrated that neurologic and psychiatric problems persist in 10-50% of brain trauma patients and maybe severe enough that cognitive defects never return to a pre-injury state.

Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries
Graph displaying increased risk of neurodegeneration with a brain injury. Image source: Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

Any injury to the brain can generate significant loss of brain volume, which in turn can initiate neuropathological changes, such as the presence of certain biomarkers (β-amyloid and tau), as well as neuroinflammatory changes. These changes can cause a younger aged brain to have symptoms that resemble an older neurodegenerative brain.

Cortechs.ai | Volumetric neuroimaging and traumatic brain injuries
T1-weighted coronal images displaying hippocampal atrophy, ventricular dilation and sulcal widening in both an 86 year old patient clinically diagnosed with Alzheimer’s disease and a 14 year old patient with severe TBI, as compared to a healthy 14 year old. Image source: Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

Using MRI scans and sophisticated software tools for quantitative imaging (NeuroQuant) to analyze the resulting images has become a significant element in the assessment of patients with TBI. Volumetric MRI studies performed after a brain injury can provide physicians with regional and whole brain volumes, which can be followed over time. This is especially meaningful, as global and regional brain atrophy from a single minor brain injury or concussion, can be detected one year after the injury.

NeuroQuant is a leading medical device software that automatically and accurately segments and calculates brain structure volumes from the 3D MR images, thereby providing anatomic information about the brain in a non-invasive fashion.

For physicians evaluating TBI, the Triage Brain Atrophy report provides volume measurements of 39 left and right brain structures and indicates the patient’s brain structure volume measurements as compared to a healthy population (Cortechs.ai’ normative reference data). This information provides physicians with an accurate indication of where an individual’s brain structure volumes are compared with their age- and gender-matched peers. The Triage Brain Atrophy report provides critical supporting quantitative volumetric data to aid physicians in their assessment of TBI.


References:

[1]        Bigler, Erin D. (2013). Traumatic brain injury, neuroimaging and neurodegeneration. Frontiers in Human Neuroscience, 7(395):1-15.

[2]        Zhou, Y., Kierans, A., et al. (2013). Mild traumatic brain injury: longitudinal regional brain volume changes. Radiology: (3) 267:880-890.

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.
Scroll to Top